Fetuin‐A, a new vascular biomarker of cognitive decline in older adults
- 11 December 2013
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 81 (1) , 134-140
Abstract
Summary: Objectives: Fetuin‐A is an abundant plasma protein known to predict vascular disease. Fetuin‐A levels are lower in patients with Alzheimer's disease in proportion to the severity of cognitive impairment, but their association with normal cognitive ageing is unknown. We evaluated the association of serum fetuin‐A levels with cognitive function in community‐dwelling older adults.Design/Patients/Measurements: A population‐based study of 1382 older adults (median age 75) who had plasma fetuin‐A levels and cognitive function evaluated in 1992–1996; 855 had repeat cognitive function assessment a median of 4 years later.Results: Adjusting for age, sex, education and depression, higher levels of fetuin‐A were associated with better baseline performance on the Mini‐Mental Status Exam (MMSE; P = 0·012) and a tendency for better Trails Making B scores (P = 0·066). In longitudinal analyses, the likelihood of a major decline (highest decile of change) in Trails B was 29% lower (P = 0·010) for each SD higher baseline fetuin‐A level; odds of major decline in MMSE was 42% lower (P = 0·005) per SD higher fetuin‐A for individuals with no known CVD, but were not related to fetuin‐A in those with CVD (P = 0·33). Fetuin‐A was not related to Category Fluency performance. Results were independent of multiple vascular risk factors and comorbid conditions.Conclusions: Higher plasma fetuin‐A concentrations are associated with better performance on tests of global cognitive function and executive function and with less likelihood of major decline in these cognitive abilities over a 4‐year period. Fetuin‐A may serve as a biological link between vascular disease and normal age‐related cognitive decline.Keywords
Funding Information
- NHLBI (R01HL096851)
- NIA (AG028507)
- NIA (AG018339)
This publication has 35 references indexed in Scilit:
- Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older AdultsDiabetes Care, 2013
- The Association of Fetuin-A With Cardiovascular Disease Mortality in Older Community-Dwelling AdultsJACC, 2012
- The Associations of Fetuin-A With Subclinical Cardiovascular Disease in Community-Dwelling PersonsJACC, 2011
- Vascular basis for brain degeneration: faltering controls and risk factors for dementiaNutrition Reviews, 2010
- Peripheral Administration of Fetuin-A Attenuates Early Cerebral Ischemic Injury in RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Plasma Fetuin-A Levels and the Risk of Type 2 DiabetesDiabetes, 2008
- Fetuin-A and Incident Diabetes Mellitus in Older PersonsJAMA, 2008
- Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin ProductionPLOS ONE, 2008
- Novel insights into vascular calcificationKidney International, 2006
- The synthesis of human α‐2‐HS glycoprotein is down‐regulated by cytokines in hepatoma HepG2 cellsFEBS Letters, 1988